Henshaw Capital’s Celgene Corp CELG Stock Holding History

Henshaw Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,350	Closed	-$210K	–	361
2018 Q3	$210K	Buy	+2,350	New	+$208K	0.02%	289
2017 Q3	–	Sell	-3,033	Closed	-$394K	–	323
2017 Q2	$394K	Hold	3,033	–	–	0.04%	178
2017 Q1	$377K	Hold	3,033	–	–	0.04%	182
2016 Q4	$351K	Hold	3,033	–	–	0.04%	180
2016 Q3	$317K	Hold	3,033	–	–	0.04%	185
2016 Q2	$299K	Buy	+3,033	New	+$314K	0.04%	187

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Henshaw Capital's CELG Position: Q4 2018 in Review

Henshaw Capital sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,350 shares — an estimated $210K sold.

Henshaw Capital first reported a position in CELG in Q2 2016 and held it in 6 quarters. The position peaked at $394K in Q2 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Henshaw Capital reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Henshaw Capital sold 2,350 Celgene Corp shares in Q4 2018, an estimated $210K.
Henshaw Capital first reported a position in Celgene Corp in Q2 2016 and held it in 6 quarters.
Henshaw Capital's Celgene Corp position peaked at $394K in Q2 2017.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Henshaw Capital's 13F filing for Q4 2018, filed 28 May 2026.